Roche claims EU okay for Herceptin/Perjeta combination PhesgoRoche has secured EU approval for Phesgo, a fixed-dose combination of its breast cancer drugs Herceptin and Perjeta Share XRoche claims EU okay for Herceptin/Perjeta combination Phesgohttps://pharmaphorum.com/news/roches-claims-eu-okay-for-herceptin-perjeta-combination-phesgo/
Roche’s Herceptin/Perjeta combo product nears EU approvalThe EMA’s human medicines committee has recommended approval of a fixed-dose combination of Roche’s breast cancer drugs Herceptin Share XRoche’s Herceptin/Perjeta combo product nears EU approvalhttps://pharmaphorum.com/news/roches-herceptin-perjeta-combo-product-nears-eu-approval/
